Overexpression of LCN2 promoted a mesenchymal-like cell morphology accompanied by increased expression of mesenchymal markers (Snail, Twist, N-cadherin, fibronectin and MMP9) that contribute to invasiveness, which accounts for their role in enhancing tumor cell motility in metastasis [25, 26]. The gene discussed is CDH2; the disease is neoplasm.